Page last updated: 2024-08-16

phenylpropanolamine and Nervous System Disorders

phenylpropanolamine has been researched along with Nervous System Disorders in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (66.67)	18.7374
1990's	1 (16.67)	18.2507
2000's	1 (16.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Saltzman, MB	1
Mueller, SM	1
Albrecht, D; Anderson, R; Appell, RA; Boone, T; Dmochowski, R; Lama, D; Miklos, J; Roach, M; Saltzstein, D; Sand, P; Staskin, DR; Zinner, N	1
Jarvis, MF; Wagner, GC	1
Walker, JS	1
Duggan, D; Graham, JD; Mueller, SM	1

Trials

1 trial(s) available for phenylpropanolamine and Nervous System Disorders

Article	Year
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study. Mayo Clinic proceedings, 2001, Volume: 76, Issue:4 Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nervous System Diseases; Phenylpropanolamine; Probability; Prospective Studies; Reference Values; Severity of Illness Index; Statistics, Nonparametric; Tartrates; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence, Stress; Urination Disorders; Xerostomia	2001

Article

Year

Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.

Mayo Clinic proceedings, 2001, Volume: 76, Issue:4

Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nervous System Diseases; Phenylpropanolamine; Probability; Prospective Studies; Reference Values; Severity of Illness Index; Statistics, Nonparametric; Tartrates; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence, Stress; Urination Disorders; Xerostomia

2001

Other Studies

5 other study(ies) available for phenylpropanolamine and Nervous System Disorders

Article	Year
PPA and neurologic complications. Neurology, 1984, Volume: 34, Issue:4 Topics: Humans; Nervous System Diseases; Phenylpropanolamine	1984
Neurologic complications of phenylpropanolamine use. Neurology, 1983, Volume: 33, Issue:5 Topics: Adolescent; Adult; Chromatography, Thin Layer; Female; Headache; Humans; Male; Nervous System Diseases; Phenylpropanolamine; Psychoses, Substance-Induced; Seizures	1983
Evaluation of the pharmacological similarities between phenylpropanolamine and amphetamine: effects on schedule-controlled behavior. Synapse (New York, N.Y.), 1990, Volume: 6, Issue:1 Topics: alpha-Methyltyrosine; Amphetamine; Animals; Conditioning, Operant; Male; Methyltyrosines; Nervous System Diseases; Phenylpropanolamine; Rats; Rats, Inbred Strains; Reinforcement Schedule; Reserpine; Tyrosine 3-Monooxygenase	1990
Phenylpropanolamine potentiates caffeine neurotoxicity in rats. Journal of pharmaceutical sciences, 1989, Volume: 78, Issue:12 Topics: Animals; Appetite Depressants; Blood Proteins; Caffeine; Chromatography, High Pressure Liquid; Drug Synergism; Male; Nervous System Diseases; Phenylpropanolamine; Protein Binding; Rats; Rats, Inbred Strains; Seizures	1989
Neurologic signs and symptoms related to over-the-counter diet pills. Indiana medicine : the journal of the Indiana State Medical Association, 1985, Volume: 78, Issue:5 Topics: Adolescent; Adult; Appetite Depressants; Dose-Response Relationship, Drug; Female; Humans; Male; Nervous System Diseases; Phenylpropanolamine	1985